Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Low

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
The Lancet. Gastroenterology & Hepatology|February 10, 2023
Global reporting of progress towards elimination of hepatitis B and hepatitis CFuqiang Cui, Sarah Blach, Casimir Manzengo Mingiedi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 17, 2024
Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate CancerW Robert Lee, James J Dignam, Mahul B Amin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 2020
Investment Case for a Comprehensive Package of Interventions Against Hepatitis B in China: Applied Modeling to Help National Strategy PlanningShevanthi Nayagam, Polin Chan, Kun Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2016
Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate CancerW Robert Lee, James J Dignam, Mahul B Amin, et al.
Journal of the International AIDS Society|October 8, 2025
Harnessing digital health data for person-centred HIV prevention monitoring: a survey of national health information systemsShona Dalal, Bradley Mathers, Dominik Stelzle, et al.
Global Health Action|March 6, 2018
Developing and implementing national health identifiers in resource limited countries: why, what, who, when and how?Eduard J Beck, J Mark Shields, Gaurang Tanna, et al.
Medrxiv : the Preprint Server for Health Sciences|February 19, 2024
Localized high-risk prostate cancer harbors an androgen receptor low subpopulation susceptible to HER2 inhibitionScott Wilkinson, Anson T Ku, Rosina T Lis, et al.
Plos Medicine|June 8, 2021
Ending AIDS as a public health threat by 2030: Time to reset targets for 2025Paul R De Lay, Adèle Benzaken, Quarraisha Abdool Karim, et al.
The Lancet. Gastroenterology & Hepatology|March 30, 2023
Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysisAdelina Artenie, Jack Stone, Hannah Fraser, et al.
The Journal of Clinical Investigation|September 4, 2025
Localized high-risk prostate cancer harbors an androgen receptor activity-low subpopulation susceptible to HER2 inhibitionScott Wilkinson, Anson T Ku, Rosina T Lis, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
The Lancet. Gastroenterology & Hepatology|February 10, 2023
Global reporting of progress towards elimination of hepatitis B and hepatitis CFuqiang Cui, Sarah Blach, Casimir Manzengo Mingiedi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 17, 2024
Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate CancerW Robert Lee, James J Dignam, Mahul B Amin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 2020
Investment Case for a Comprehensive Package of Interventions Against Hepatitis B in China: Applied Modeling to Help National Strategy PlanningShevanthi Nayagam, Polin Chan, Kun Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2016
Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate CancerW Robert Lee, James J Dignam, Mahul B Amin, et al.
Journal of the International AIDS Society|October 8, 2025
Harnessing digital health data for person-centred HIV prevention monitoring: a survey of national health information systemsShona Dalal, Bradley Mathers, Dominik Stelzle, et al.
Global Health Action|March 6, 2018
Developing and implementing national health identifiers in resource limited countries: why, what, who, when and how?Eduard J Beck, J Mark Shields, Gaurang Tanna, et al.
Medrxiv : the Preprint Server for Health Sciences|February 19, 2024
Localized high-risk prostate cancer harbors an androgen receptor low subpopulation susceptible to HER2 inhibitionScott Wilkinson, Anson T Ku, Rosina T Lis, et al.
Plos Medicine|June 8, 2021
Ending AIDS as a public health threat by 2030: Time to reset targets for 2025Paul R De Lay, Adèle Benzaken, Quarraisha Abdool Karim, et al.
The Lancet. Gastroenterology & Hepatology|March 30, 2023
Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysisAdelina Artenie, Jack Stone, Hannah Fraser, et al.
The Journal of Clinical Investigation|September 4, 2025
Localized high-risk prostate cancer harbors an androgen receptor activity-low subpopulation susceptible to HER2 inhibitionScott Wilkinson, Anson T Ku, Rosina T Lis, et al.
Pageof 14